Who is on it, and how far along Every drug ChEMBL records acting on ESR1, by the furthest stage it has reached for any use, coloured by modality.
How to read this Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
Approved13 Estrogens, conjugated Estrogens, conjugated SponsorPfizer ModalityOther ActionAgonist Open trials16 Estriol Estriol SponsorMeLSyTech, Ltd ModalitySmall molecule ActionModulator Open trials10 Toremifene Toremifene SponsorKyowa Kirin ModalitySmall molecule ActionModulator Open trials8 Bazedoxifene Bazedoxifene SponsorWyeth is now a wholly owned subsidiary of Pfizer ModalitySmall molecule ActionModulator Open trials6 Lasofoxifene Lasofoxifene SponsorAzure Biotech ModalitySmall molecule ActionModulator Open trials3 Estrogens, conjugated synthetic a Estrogens, conjugated synthetic a SponsorAspen ModalityOther ActionAgonist Open trials1 Cyclofenil Cyclofenil SponsorNot known ModalitySmall molecule ActionModulator Open trials0 Diethylstilbestrol diphosphate Diethylstilbestrol diphosphate SponsorBayer ModalitySmall molecule ActionAgonist Open trials0 Estetrol anhydrous Estetrol anhydrous SponsorEstetra ModalitySmall molecule ActionAgonist Open trials0 Estrogens, esterified Estrogens, esterified SponsorSolvay ModalityOther ActionAgonist Open trials0 Ospemifene Ospemifene SponsorDuchesnay ModalitySmall molecule ActionModulator Open trials0 Quinestrol Quinestrol SponsorPfizer ModalitySmall molecule ActionAgonist Open trials0 Synthetic conjugated estrogens, b Synthetic conjugated estrogens, b SponsorTeva Pharmaceutical Industries ModalityOther ActionAgonist Open trials0 Phase 34 Acolbifene Acolbifene SponsorNot known ModalitySmall molecule ActionModulator Open trials1 Afimoxifene Afimoxifene SponsorAscend Therapeutics US ModalitySmall molecule ActionModulator Open trials1 Arzoxifene Arzoxifene SponsorEli Lilly ModalitySmall molecule ActionModulator Open trials0 Droloxifene Droloxifene SponsorNot known ModalitySmall molecule ActionModulator Open trials0 Phase 25 Allylestrenol Allylestrenol SponsorNot known ModalitySmall molecule ActionAgonist Open trials0 Fispemifene Fispemifene SponsorQuatRx Pharmaceuticals Company ModalitySmall molecule ActionModulator Open trials0 Idoxifene Idoxifene SponsorNot known ModalitySmall molecule ActionModulator Open trials0 LY2245461 LY2245461 SponsorNot known ModalityOther ActionModulator Open trials0 MK-6913 MK-6913 SponsorNot known ModalitySmall molecule ActionAgonist Open trials0 Phase 11 CHF4227 CHF4227 SponsorNot known ModalitySmall molecule ActionModulator Open trials0
Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 14 of 23 act as: Estrogen receptor modulator; the rest name their own mechanism. The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 35 in all, from ClinicalTrials.gov. Trial Drug Phase Status Lead sponsor First posted Trastuzumab Rezetecan Followed by Pyrotinib, Fulvestrant, and Dalpiciclib in HR-Positive, HER2-Positive Advanced Breast Cancer Estrogens, conjugated Phase 3 Not yet recruiting Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Oct 23, 2026 Tolerability of Dalpiciclib vs. Abemaciclib/Ribociclib in Early HR+/HER2- Breast Cancer Toremifene Not applicable Not yet recruiting Henan Cancer Hospital Jul 16, 2026 Neoadjuvant Dalpiciclib + AI → SHR-A1811 for HR+/HER2-Low Breast Cancer Estrogens, conjugated, Estrogens, conjugated synthetic a Phase 2 Not yet recruiting Tang-Du Hospital Jun 1, 2026 Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study Toremifene Phase 2 Recruiting Fujian Cancer Hospital May 12, 2026 A Study of Single Dose of BL0175 in Postmenopausal Women Estrogens, conjugated Phase 1 Not yet recruiting Shanghai Best-Link Bioscience, LLC Jan 26, 2026 The Effects of Adjunctive Therapy With Vaginal Tablets Lactobacillus Acidophilus and a Low Dose Estriol (Gynoflor®) to Prolong Pregnancy Time in Preterm Labor, A Randomized Controlled Trial Estriol Not applicable Not yet recruiting Queen Savang Vadhana Memorial Hospital, Thailand Jan 15, 2026 ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer Estrogens, conjugated Phase 1 / Phase 2 Recruiting Kristina A. Fanucci Sep 30, 2025 Microbiome-Modulating Prophylaxis RCT: Antibiotic vs Gynoflor in Postmenopausal Women With Recurrent Cystitis Estriol Phase 4 Recruiting Mahidol University Sep 22, 2025 De-escalation Therapy in Stage I ER-Positive Breast Cancer: A Non-Inferiority Trial Toremifene Phase 3 Not yet recruiting Fudan University Sep 4, 2025 A Clinical Study of SYS6023 in Patients With Advanced Solid Tumors Estrogens, conjugated Phase 1 Recruiting CSPC Megalith Biopharmaceutical Co.,Ltd. Aug 8, 2025 Vaginal Estrogen for Improvement of Outcomes Following Pelvic Organ Prolapse Surgery Estrogens, conjugated Phase 3 Recruiting Sarah Wozney Jun 22, 2025 Er:YAG Laser Combined With Vaginal Estriol for Genitourinary Syndrome of Menopause Estriol Not applicable Recruiting University of Nove de Julho Mar 13, 2025 Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome Estriol Phase 4 Recruiting Aarhus University Hospital Aug 26, 2024 Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome Estriol Phase 4 Recruiting Aarhus University Hospital Aug 9, 2024 Dalpiciclib Plus Toremifene for First-line Advanced HR Positive and HER2 Negative Breast Cancer Toremifene Phase 2 Recruiting Tianjin Medical University Cancer Institute and Hospital Jul 10, 2024 Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder Estrogens, conjugated Phase 4 Recruiting Mackay Memorial Hospital Jun 28, 2024 The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer Estrogens, conjugated Phase 2 Recruiting Dana-Farber Cancer Institute Jun 3, 2024 Effect of Local Estriol Treatment Before Vaginal Repair Surgery Estriol Phase 3 Active, not recruiting Hatice Tukenmez Kurnaz Apr 30, 2024 Proof of Concept Study of Vaginal AZU-101 in Vulvovaginal Atrophy in Postmenopausal Women Lasofoxifene Phase 2 Recruiting Azure Biotech Inc. Jan 9, 2024 Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer Acolbifene Phase 2 Recruiting National Cancer Institute (NCI) Jul 12, 2023 Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01) Toremifene Phase 3 Recruiting Fudan University Jun 6, 2023 Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast Cancer Toremifene Phase 2 Recruiting Fudan University May 16, 2023 Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation Lasofoxifene Phase 3 Recruiting LeonaBio Jan 25, 2023 Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy Toremifene Phase 2 Recruiting UNC Lineberger Comprehensive Cancer Center Jul 25, 2022 Treatment of Vaginal Atrophy With Low Intensity Nanosecond Neodymium Laser Estriol Not applicable Recruiting MeLSyTech, Ltd Apr 19, 2022 Endometriosis and Microvascular Dysfunction; Simvastatin and Duavee Bazedoxifene Phase 4 Enrolling by invitation Penn State University Sep 28, 2021 Reducing Pregnancy Risks: The Mastery Lifestyle Intervention Estriol Not applicable Recruiting Microgen LLC Aug 19, 2021 Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens Bazedoxifene Phase 2 Active, not recruiting University of Kansas Medical Center Mar 29, 2021 Affect of Duavive on Mood & Anxiety Symptoms Bazedoxifene Phase 1 Recruiting St. Joseph's Healthcare Hamilton Jul 20, 2020 Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS) Toremifene Phase 2 Active, not recruiting Fudan University May 12, 2020 Bazedoxifene -Treatment for Women With Schizophrenia Bazedoxifene Phase 4 Recruiting The Alfred Oct 3, 2019 Advancing Postmenopausal Preventive Therapy Bazedoxifene Phase 2 Active, not recruiting University of Southern California Sep 25, 2019 Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast Afimoxifene Phase 2 Active, not recruiting Northwestern University Jul 5, 2019 Examination of Efficacy and Safety of Other Anti-Resorption Drugs After 2-year-Denosumab Therapy in Japanese Osteoporosis Patients Bazedoxifene Phase 2 Recruiting Shinshu University Nov 27, 2018 I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Lasofoxifene Phase 2 Recruiting QuantumLeap Healthcare Collaborative Jan 5, 2010
Show all 35Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2093866 , ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov , checked daily; this page as of 2026-11-22. ChEMBL and Open Targets